Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haramburu

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Epidemiology|January 1, 1996
Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approachP Tubert-Bitter, B Begaud, Y Moride, et al.
Therapie|September 1, 1985
[Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods]J C Péré, M H Godin, B Bégaud, et al.
Presse Medicale (Paris, France : 1983)|February 22, 2000
[Incidence and prevalence of adverse drug reactions]F Haramburu, P Pouyanne, J L Imbs, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Spontaneous reporting of adverse drug reactions: who reports and what?P Tubert-Bitter, F Haramburu, B Begaud, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1984
[3 new cases of hypoprothrombinemia induced by latamoxef]J M Ragnaud, H Dabadie, F Haramburu, et al.
Annales De Medecine Interne|June 16, 2000
[Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction]X Thirion, K Barrau, J Micallef, et al.
Biometrics|May 13, 2009
False discovery rate estimation for frequentist pharmacovigilance signal detection methodsI Ahmed, C Dalmasso, F Haramburu, et al.
Therapie|September 1, 1984
[Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians]B Begaud, F Haramburu, J C Péré, et al.
Therapie|March 1, 1987
[Information centers on undesirable effects of drugs: also on alerting function]B Bégaud, J C Péré, P Tubert, et al.
La Revue De Medecine Interne|April 4, 2006
[Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database]A Doussau de Bazignan, F Thiessard, G Miremont-Salamé, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Epidemiology|January 1, 1996
Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approachP Tubert-Bitter, B Begaud, Y Moride, et al.
Therapie|September 1, 1985
[Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods]J C Péré, M H Godin, B Bégaud, et al.
Presse Medicale (Paris, France : 1983)|February 22, 2000
[Incidence and prevalence of adverse drug reactions]F Haramburu, P Pouyanne, J L Imbs, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Spontaneous reporting of adverse drug reactions: who reports and what?P Tubert-Bitter, F Haramburu, B Begaud, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1984
[3 new cases of hypoprothrombinemia induced by latamoxef]J M Ragnaud, H Dabadie, F Haramburu, et al.
Annales De Medecine Interne|June 16, 2000
[Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction]X Thirion, K Barrau, J Micallef, et al.
Biometrics|May 13, 2009
False discovery rate estimation for frequentist pharmacovigilance signal detection methodsI Ahmed, C Dalmasso, F Haramburu, et al.
Therapie|September 1, 1984
[Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians]B Begaud, F Haramburu, J C Péré, et al.
Therapie|March 1, 1987
[Information centers on undesirable effects of drugs: also on alerting function]B Bégaud, J C Péré, P Tubert, et al.
La Revue De Medecine Interne|April 4, 2006
[Psychiatric adverse effects of fluoroquinolone: review of cases from the French pharmacologic surveillance database]A Doussau de Bazignan, F Thiessard, G Miremont-Salamé, et al.
Pageof 7